个人光照模式与 2 型糖尿病发病率:对 1 300 万小时光传感器数据和 67 万人年前瞻性观察结果的分析

IF 13.6 Q1 HEALTH CARE SCIENCES & SERVICES Lancet Regional Health-Europe Pub Date : 2024-07-01 DOI:10.1016/j.lanepe.2024.100943
Daniel P. Windred , Angus C. Burns , Martin K. Rutter , Chris Ho Ching Yeung , Jacqueline M. Lane , Qian Xiao , Richa Saxena , Sean W. Cain , Andrew J.K. Phillips
{"title":"个人光照模式与 2 型糖尿病发病率:对 1 300 万小时光传感器数据和 67 万人年前瞻性观察结果的分析","authors":"Daniel P. Windred ,&nbsp;Angus C. Burns ,&nbsp;Martin K. Rutter ,&nbsp;Chris Ho Ching Yeung ,&nbsp;Jacqueline M. Lane ,&nbsp;Qian Xiao ,&nbsp;Richa Saxena ,&nbsp;Sean W. Cain ,&nbsp;Andrew J.K. Phillips","doi":"10.1016/j.lanepe.2024.100943","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Light at night disrupts circadian rhythms, and circadian disruption is a risk factor for type 2 diabetes. Whether personal light exposure predicts diabetes risk has not been demonstrated in a large prospective cohort. We therefore assessed whether personal light exposure patterns predicted risk of incident type 2 diabetes in UK Biobank participants, using ∼13 million hours of light sensor data.</p></div><div><h3>Methods</h3><p>Participants (N = 84,790, age (M ± SD) = 62.3 ± 7.9 years, 58% female) wore light sensors for one week, recording day and night light exposure. Circadian amplitude and phase were modeled from weekly light data. Incident type 2 diabetes was recorded (1997 cases; 7.9 ± 1.2 years follow-up; excluding diabetes cases prior to light-tracking). Risk of incident type 2 diabetes was assessed as a function of day and night light, circadian phase, and circadian amplitude, adjusting for age, sex, ethnicity, socioeconomic and lifestyle factors, and polygenic risk.</p></div><div><h3>Findings</h3><p>Compared to people with dark nights (0–50th percentiles), diabetes risk was incrementally higher across brighter night light exposure percentiles (50–70th: multivariable-adjusted HR = 1.29 [1.14–1.46]; 70–90th: 1.39 [1.24–1.57]; and 90–100th: 1.53 [1.32–1.77]). Diabetes risk was higher in people with lower modeled circadian amplitude (aHR = 1.07 [1.03–1.10] per SD), and with early or late circadian phase (aHR range: 1.06–1.26). Night light and polygenic risk independently predicted higher diabetes risk. The difference in diabetes risk between people with bright and dark nights was similar to the difference between people with low and moderate genetic risk.</p></div><div><h3>Interpretation</h3><p>Type 2 diabetes risk was higher in people exposed to brighter night light, and in people exposed to light patterns that may disrupt circadian rhythms. Avoidance of light at night could be a simple and cost-effective recommendation that mitigates risk of diabetes, even in those with high genetic risk.</p></div><div><h3>Funding</h3><p><span>Australian Government Research Training Program</span>.</p></div>","PeriodicalId":53223,"journal":{"name":"Lancet Regional Health-Europe","volume":null,"pages":null},"PeriodicalIF":13.6000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666776224001108/pdfft?md5=5260c5c06580e719d3b58d4b127def7f&pid=1-s2.0-S2666776224001108-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Personal light exposure patterns and incidence of type 2 diabetes: analysis of 13 million hours of light sensor data and 670,000 person-years of prospective observation\",\"authors\":\"Daniel P. Windred ,&nbsp;Angus C. Burns ,&nbsp;Martin K. Rutter ,&nbsp;Chris Ho Ching Yeung ,&nbsp;Jacqueline M. Lane ,&nbsp;Qian Xiao ,&nbsp;Richa Saxena ,&nbsp;Sean W. Cain ,&nbsp;Andrew J.K. Phillips\",\"doi\":\"10.1016/j.lanepe.2024.100943\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Light at night disrupts circadian rhythms, and circadian disruption is a risk factor for type 2 diabetes. Whether personal light exposure predicts diabetes risk has not been demonstrated in a large prospective cohort. We therefore assessed whether personal light exposure patterns predicted risk of incident type 2 diabetes in UK Biobank participants, using ∼13 million hours of light sensor data.</p></div><div><h3>Methods</h3><p>Participants (N = 84,790, age (M ± SD) = 62.3 ± 7.9 years, 58% female) wore light sensors for one week, recording day and night light exposure. Circadian amplitude and phase were modeled from weekly light data. Incident type 2 diabetes was recorded (1997 cases; 7.9 ± 1.2 years follow-up; excluding diabetes cases prior to light-tracking). Risk of incident type 2 diabetes was assessed as a function of day and night light, circadian phase, and circadian amplitude, adjusting for age, sex, ethnicity, socioeconomic and lifestyle factors, and polygenic risk.</p></div><div><h3>Findings</h3><p>Compared to people with dark nights (0–50th percentiles), diabetes risk was incrementally higher across brighter night light exposure percentiles (50–70th: multivariable-adjusted HR = 1.29 [1.14–1.46]; 70–90th: 1.39 [1.24–1.57]; and 90–100th: 1.53 [1.32–1.77]). Diabetes risk was higher in people with lower modeled circadian amplitude (aHR = 1.07 [1.03–1.10] per SD), and with early or late circadian phase (aHR range: 1.06–1.26). Night light and polygenic risk independently predicted higher diabetes risk. The difference in diabetes risk between people with bright and dark nights was similar to the difference between people with low and moderate genetic risk.</p></div><div><h3>Interpretation</h3><p>Type 2 diabetes risk was higher in people exposed to brighter night light, and in people exposed to light patterns that may disrupt circadian rhythms. Avoidance of light at night could be a simple and cost-effective recommendation that mitigates risk of diabetes, even in those with high genetic risk.</p></div><div><h3>Funding</h3><p><span>Australian Government Research Training Program</span>.</p></div>\",\"PeriodicalId\":53223,\"journal\":{\"name\":\"Lancet Regional Health-Europe\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":13.6000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2666776224001108/pdfft?md5=5260c5c06580e719d3b58d4b127def7f&pid=1-s2.0-S2666776224001108-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Regional Health-Europe\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666776224001108\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Regional Health-Europe","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666776224001108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景夜间光线会扰乱昼夜节律,而昼夜节律紊乱是 2 型糖尿病的一个风险因素。在大型前瞻性队列中,尚未证实个人光照是否能预测糖尿病风险。因此,我们利用 1300 万小时的光传感器数据,评估了英国生物库参与者的个人光暴露模式是否能预测 2 型糖尿病的发病风险。方法参与者(N = 84,790 人,年龄(M ± SD)= 62.3 ± 7.9 岁,58% 为女性)佩戴光传感器一周,记录昼夜光暴露。昼夜节律振幅和相位根据每周的光照数据进行建模。记录了2型糖尿病的发病情况(1997例;7.9 ± 1.2年随访;不包括光跟踪之前的糖尿病病例)。研究结果与黑夜人群(0-50百分位数)相比,夜间光照较亮的人群患糖尿病的风险逐渐升高(50-70百分位数:经多变量调整的HR = 1.29 [1.14-1.46];70-90百分位数:经多变量调整的HR = 1.39 [1.24-1.46]):1.39[1.24-1.57];90-100th:1.53 [1.32-1.77]).昼夜节律振幅模型较低(aHR = 1.07 [1.03-1.10] per SD)、昼夜节律相位较早或较晚(aHR 范围:1.06-1.26)的人群患糖尿病的风险较高。夜光和多基因风险可独立预测较高的糖尿病风险。夜间光线明亮和黑暗的人群之间的糖尿病风险差异与遗传风险较低和中等的人群之间的差异相似。夜间避光可能是一项简单而又具有成本效益的建议,它可以降低糖尿病风险,即使是那些具有高遗传风险的人。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Personal light exposure patterns and incidence of type 2 diabetes: analysis of 13 million hours of light sensor data and 670,000 person-years of prospective observation

Background

Light at night disrupts circadian rhythms, and circadian disruption is a risk factor for type 2 diabetes. Whether personal light exposure predicts diabetes risk has not been demonstrated in a large prospective cohort. We therefore assessed whether personal light exposure patterns predicted risk of incident type 2 diabetes in UK Biobank participants, using ∼13 million hours of light sensor data.

Methods

Participants (N = 84,790, age (M ± SD) = 62.3 ± 7.9 years, 58% female) wore light sensors for one week, recording day and night light exposure. Circadian amplitude and phase were modeled from weekly light data. Incident type 2 diabetes was recorded (1997 cases; 7.9 ± 1.2 years follow-up; excluding diabetes cases prior to light-tracking). Risk of incident type 2 diabetes was assessed as a function of day and night light, circadian phase, and circadian amplitude, adjusting for age, sex, ethnicity, socioeconomic and lifestyle factors, and polygenic risk.

Findings

Compared to people with dark nights (0–50th percentiles), diabetes risk was incrementally higher across brighter night light exposure percentiles (50–70th: multivariable-adjusted HR = 1.29 [1.14–1.46]; 70–90th: 1.39 [1.24–1.57]; and 90–100th: 1.53 [1.32–1.77]). Diabetes risk was higher in people with lower modeled circadian amplitude (aHR = 1.07 [1.03–1.10] per SD), and with early or late circadian phase (aHR range: 1.06–1.26). Night light and polygenic risk independently predicted higher diabetes risk. The difference in diabetes risk between people with bright and dark nights was similar to the difference between people with low and moderate genetic risk.

Interpretation

Type 2 diabetes risk was higher in people exposed to brighter night light, and in people exposed to light patterns that may disrupt circadian rhythms. Avoidance of light at night could be a simple and cost-effective recommendation that mitigates risk of diabetes, even in those with high genetic risk.

Funding

Australian Government Research Training Program.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
19.90
自引率
1.40%
发文量
260
审稿时长
9 weeks
期刊介绍: The Lancet Regional Health – Europe, a gold open access journal, is part of The Lancet's global effort to promote healthcare quality and accessibility worldwide. It focuses on advancing clinical practice and health policy in the European region to enhance health outcomes. The journal publishes high-quality original research advocating changes in clinical practice and health policy. It also includes reviews, commentaries, and opinion pieces on regional health topics, such as infection and disease prevention, healthy aging, and reducing health disparities.
期刊最新文献
Blood-based biomarkers in the oldest old: towards Alzheimer's disease detection in primary care Emerging data on SGLT2 benefits in acute coronary syndromes Ultra-processed foods and type 2 diabetes: more fundamental research is needed Getting to the heart of it: sex and gender considerations in the management of cardiovascular disease Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1